article thumbnail

Endothelin System in Hypertension and Chronic Kidney Disease

Hypertension Journal

ET (endothelin) is a powerful vasoconstrictor 21-amino acid peptide present in many tissues, which exerts many physiological functions across the body and participates as a mediator in many pathological conditions. Hypertension, Ahead of Print.

article thumbnail

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat

DAIC

a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. Obstructive sleep apnea carries significant physiological and psychological impacts on health. tim.hodson Wed, 01/08/2025 - 14:11 Jan.

article thumbnail

Physiology Friday #196: Resistance Training and Heart Health

Physiologically Speaking

Welcome to the Physiology Friday newsletter. Physiologically Speaking is a reader-supported publication. This newsletter is brought to you by Examine.com — the best place on the internet for health and nutrition information — and my new eBook, “VO2 Max Essentials.”

article thumbnail

Physiology Friday #196: Resistance Training and Heart Health

Physiologically Speaking

Welcome to the Physiology Friday newsletter. Physiologically Speaking is a reader-supported publication. This newsletter is brought to you by Examine.com — the best place on the internet for health and nutrition information — and my new eBook, “VO2 Max Essentials.”

article thumbnail

Tangram of Sodium and Fluid Balance: Salt Series

Hypertension Journal

Homeostasis of fluid and electrolytes is a tightly controlled physiological process. Failure of this process is a hallmark of hypertension, chronic kidney disease, heart failure, and other acute and chronic diseases. Hypertension, Ahead of Print.

article thumbnail

Abstract 4143844: Multidisciplinary management of a pregnant patient with advanced systolic heart failure

Circulation

A 35-year-old gravida 1, para 0 with biventricular heart failure (LVEF 25%), nonischemic cardiomyopathy, history stroke, history of left ventricular thrombus, class III obesity, and chronic kidney disease who had been followed by Cardio-Obstetrics throughout her pregnancy presented at 34 weeks gestation for planned induction of labor.

article thumbnail

Prevalence of Systemic Hypertension and the Effects of Cerebral Revascularization in Patients With Moyamoya Disease

Stroke: Vascular and Interventional Neurology

6.04]), kidney disease (OR, 18.98 [95% CI, 1.80–200.47]), Its association with symptomatic presentation and observed improvement following revascularization suggests blood pressure changes, in part, are a compensatory physiological response to increased intracranial vascular resistance. After a mean follow‐up of 34.3±18.1